Education / Qualifications 

• 1992: Graduated from Dental School, NKUA, Greece 
• 1997-1999: Postgraduate Specialty Diploma in Oral Surgery 
• 2000: Master of Science in Oral Pathology, School of Dentistry NKUA, 
• 2009: Dr. Dent (PhD), School of Dentistry, NKUA, Greece 
• 2014: Master of Science in Advanced General Dental Practice, King’s, College London UK, 

Academic and professional positions held

• 1998-2009: Clinical and Research Associateof Departmentof Oral & Maxillofacial SurgeryDental School, NKUA, Greece.
• 2000- 2010: Clinical Fellow at the University Department of Oral Maxillofacial  Surgery, Children’s Hospital  of Athens  "P. & A. Kyriakou ", Athens, Greece.
• 2009-2010: Adjunct Lecturer.
• 2010-2018: Clinical and Research Associate, Clinic of Hospital Dentistry, School of Dentistry NKUA Greece.
• 2019-2021: Assistant Professor, Clinic of Hospital Dentistry, School of Dentistry NKUA Greece.
• 2021-present: Assistant Professor, Department of Oral Pathology & Hospital Dentistry, School of Dentistry NKUA Greece.

Academic and professional responsibilities

• Assistant  Professor, of Clinic of Hospital Dentistry, School of Dentistry NKUA Greece.
• 2012- Present : Undergraduate teaching: (School of Dentistry NKUA), Hospital Dentistry: Lectures (8^thsemester) 
• 2013- Present: Undergraduate teaching: (School of Dentistry NKUA), Hospital Dentistry: Clinical training (9^th& 10^thsemester)
• 2010-2012, 2014-2016, & 2018, Postgraduate program: Organization and Management of Palliative and Supportive care for Chronically Patients, (Collaboration: Faculty of Nursing NKUA & School of Medicine NKUA)
• 2015-2016 & 2017-2018:Postgraduate program: Hospital Dentistry (School of Dentistry NKUA),  
  Courses: Clinic of Hospital Dentistry & Dental Oncology Unit 1, (1^stsemester, code NOS1). / Dental management of the medically compromised patient (1^stsemester, code NOS 2). / Case presentations/Literature Review 1,(1^st semester, code NOS 3)./ Clinic of Hospital Dentistry & Dental Oncology Unit 2, (2^ndsemester, code NOS 5)/ Dental management of the oncology patient (2^ndsemester, code NOS 6)./ Clinic of Hospital Dentistry & Dental Oncology Unit 3(3^rdsemester, code NOS 8)./ Case presentations/Literature Review 2, (3^rdsemester, code NOS 11)./ Case presentations/Literature Review 3, (5^thsemester, code NOS 19).
• 2016-2017. Postgraduate program: Clinical Nursing with the following direction: Oncology and Palliative Care Nursing (Faculty of Nursing NKUA),Course: Therapeutic modalities for malignant neoplasms treatment, (code: KO14).

 Research Grants and Contracts 

• 2010  to 2013. Research program conducted by European Organization for Research and Treatment of Cancer-EORTC and collaboration of Clinic of Hospital, School of Dentistry NKUA.Research object: «Patient reported oncology patients receiving bone resorption inhibitors and / or angiogenesis inhibitors and / or conventional chemotherapeutic regimens: Prospective recording of the clinical and radiographic features of the teeth and alveolar bone prior to the therapeutically necessary dental extraction ».Principal Investigatoroutcomes in chronic myeloid leukemia» Principal Investigator:Professor O. Nicolatou-Galitis.
• 2016 - present. Research program conducted by Clinic of Hospital, School of Dentistry NKUA.Research object: «tooth extractions in oncology patients receiving bone resorption inhibitors and / or angiogenesis inhibitors and / or conventional chemotherapeutic regimens: Prospective recording of the clinical and radiographic features of the teeth and alveolar bone prior to the therapeutically necessary dental extraction ».Principal Investigator: Professor O. Nicolatou-Galitis.
• 2014 to present. Research program granted by Amgen Hellas (Amgen Protocol 20101102): Osteonecrosis of the Jaw (ONJ) Case Registry. Principal Investigator:Professor O. Nicolatou-Galitis.

Awards and Honours 

• 2010: Award for the 2^ndMeeting of the Hellenic Association of Supportive Care of the Oral Cavity in Cancer. Oral Presentation entitled: Effect of Saliva Substitutes and Oral Pilocarpine on Xerostomia and Quality of Life in Head and Neck Cancer Patients who received Radiotherapy or Chemoradiotherapy: A Preliminary  Report.E. Gatou, E. Vardas, O. Nicolatou-Galitis.
• 2010: Merit for the 2^ndMeeting of the Hellenic Association of Supportive Care of the Oral Cavity in Cancer. Oral Presentation entitled: Dental Management of the Oncology Patients in the Maternity Hospital «H. Venizelou » Seven Years Experience. M. Antoniou, L. Katraki, F. Antoniou, E. Gatou, E. Vardas.
• 2017: International Symposium ALGOS 2017, 2^ndPrize award, presentation of the Scientific Work entitled: Salivary A-Amylase levels, oral Mucositis, pain and xerostomia in head and neck cancer patients, receiving radio/chemoradiotherapy: a preliminary report.M. Kouri, O. Nicolatou-Galitis, A. Vadalouca, V. Kouloulias, G. Maropoulos, P. Kanellopoulos, E. Kyrodimos, A. Vourli, E. Papadopoulou, E. Vardas, Ch. Chatzichalepli, E. Galitis, M. Trichas, A. Zigogianni, Z. Liakouli, A. Psyrri, I. Kouvaris.

Memberships 

• Hellenic Society of Oral Oncology- HSOO (Member of the Board).
• Hellenic Society of Head and Neck Cancer – HeSHNCA.
• Multinational Association of Supportive Care in Cancer-MASCC.
• Dental association of Athens (Member of the Board &scientific committee).
• Hellenic Society of the Odontostomatological Research. 
• Hellenic Society of Oral Medicine and Pathology.
• Hellenic Society of Dentomaxillofacial Radiology.
• Board Member of the Athens Dental Association.
• Member of the Scientific Committee,Athens Dental Association.
• Member of the Organizing Committee of the 30th Hellenic Dental Congress, Athens 2010.

Research Theses 

•  “Effect of Amelogenin (Emdogain Gel) application on teeth reimplantation. A study in rats with experimentally induced arthritis ”.PhD Thesis, Athens.

Selected publications in scientific journals

• The use of crevicular fluid to assess markers of inflammation and angiogenesis, IL-17 and VEGF, in patients with solid tumors receiving zoledronic acid and/or bevacizumab.Supportive Care in Cancer,Papadopoulou E, Nicolatou-Galitis O, Papassotiriou I, Linardou H, KaragianniAik, Tsixlakis  K, Tarampikou A, Michalakakou K, Vardas E, and Bafaloukos D (2019).  published online April 17, 2019, DOI: 10.1007/s00520-019-04793-2
• Osteonecrosis of the jaw related to non-antiresorptive medications: a systematic review. Nicolatou-Galitis O,Kouri M, Papadopoulou E, Vardas E, Galiti D, Epstein JB, EladS, Campisi G, Tsoukalas N,Bektas-Kayhan K,Tan W,Body JJ,Migliorati C, Rajesh V. LallaRV,fortheMASCCBoneStudyGroup (2019).  Supportive Care in Cancer2019;27:383-394
• Systematic review of dental disease management in cancer patients. CHL. HongS. Hu, T.Haverman, M.Stokman, JJ.Napeñas, JB.Braber, E.Gerber, M.Geuke, E. Vardas, T.Waltimo, SB.Jensen, DP.Saunders. Support Care Cancer. 2018;26:155-174
• The frequency of non-syndromic distomolar teeth in a Greek population sample. A. Mitsea, E. Vardas, A. Papachatzopoulou, G. Kalfountzos, M. Leventis, K. Tsiklakis. J Clin Exp Dent. 2015;1:589-94.
• Dental extractions as the major local risk factor of bisphopshonates related jaw osteonecrosis in cancer patients receiving intravenous bisphopshonates therapy.E.Vardas, T. Coward, E. Papadopoulou, O. Nicolatou-Galitis. MOJ 2014;1:26-33.
• Osteonecrosis of the jaw in a patient with chronic myelogenous leukemia receiving imatinib - A case report with clinical implications. O.  Nicolatou-Galitis, E. Razis, D. Galiti, E.Vardas, F. Tzerbos,S. Labropoulos. Forum of Clinical Oncology.2013;4:29-33
• Generalized Aggressive Periodontitis Associated With a Plasma Cell. Gingivitis Lesion: A Case Report and Non-Surgical Treatment. AO. Parashis, E. Vardas, K. Tosios. Clinical Advances in Periodontics.2013;84:1-12.
• Experimental study of the effect of autologous platelet-rich plasma on the early phases of osteoinduction by allogenic demineralized bone matrix.M. Leventis, E. Eleftheriadis, P. Oikonomopoulou , H. Vavouraki, L. Khaldi, KL. Tosios, E.Vardas, K.Valavanis, I. Dontas. Implant Dent. 2012 ; 21:399-405.
• Oral ulcers in cancer patients who receive mTOR inhibitors: an emerging oral toxicity. O. Nicolatou-Galitis, D. Bafaloukos, G. Manolakis, P. Panayiotidis, E.Vardas, D. Galiti, H. Linardou.MOJ 2012;2:50-56.
• Jaw osteonecrosis associated with medication: Report of two cases addressing unresolved clinical research questions.O. Nicolatou-Galitis, D. Bafaloukos, E. Razis, E. Papadopoulou, H. Linardou, I. Grossi, E. Vardas, CA. Migliorati. MOJ 2012;1:45-5.
• Gingival bleeding in a patient with cervical cancer receiving bevacizumab. Report of a case. E. Papadopoulou, D. Bafaloukos, H. Linardou, E. Gatou, T. Sarri, E. Vardas, O. Nicolatou-Galitis. MOJ 2012; 1:54-56.
• Intraosseous mandibular venous malformation.E.Vardas, E. Stavrou, M. Leventis, I. Chatzistamou, I. Iatrou, C. Alexandridis. J CraniofacSurg. 2011;22:44-7.

Areas of scientific interest

• Osteonecrosis of the jaws in oncology patients 
• Oral Complications in standard Cancer Therapies
• Oral complications in cancer targeted therapies
• Oral Care in Cancer
• Quality of Life in Cancer

More content written by the author